Reducing G60 Recidivism Rates
Launched by METHODIST HEALTH SYSTEM · Feb 3, 2022
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Risk of future falls in elderly patients increases based on multiple factors including increased age and history of previous falls. However, there is limited research showing evidenced-based interventions that reduce recidivism rates related to falls. The Centers for Disease Control and Prevention (CDC) has an evidenced-based fall prevention program (Stopping Elderly Accidents, Deaths \& Injuries \[STEADI3\]). Implementation of STEADI as part of a multidisciplinary approach to fall risk assessment and prevention prior to discharge may reduce recidivism in elderly patients.
Ground level fal...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 60 years or older
- • G60 activation and admission
- • Primary admission for injury
- Exclusion Criteria:
- • Less than 60 years old
- • Admitted for non-traumatic injuries
- • Non-index admission for injury
- • Prisoners
- • Pregnant or lactating subjects
About Methodist Health System
Methodist Health System is a leading healthcare provider dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care and scientific inquiry, the organization leverages its state-of-the-art facilities and multidisciplinary expertise to conduct rigorous studies across various therapeutic areas. Methodist Health System collaborates with healthcare professionals, researchers, and industry partners to enhance the understanding of diseases and develop new treatment modalities, ensuring that cutting-edge therapies are accessible to the communities it serves. Through its clinical trial initiatives, Methodist Health System aims to contribute to the evolving landscape of medicine while prioritizing patient safety and ethical standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dallas, Texas, United States
Patients applied
Trial Officials
Sarah Bradley, RN
Principal Investigator
Methodist Health System
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials